Last Friday, the FDA granted emergency use authorization (EUA) to Gilead Sciences, Inc. (NASDAQ:GILD) remdesivir to treat patients hospitalized with COVID19. The EUA approval came within days after Gilead and NIH scientists released clinical study results demonstrating the statistical significance […]
GeoInvesting Weekly Premium Email and Call To Action Updates (April 27 – May 1) As we gear up for another week at GeoInvesting, below you’ll find the past week of coverage, in case you missed any of it. At the […]
This content is for members only